Please login to the form below

Not currently logged in
PMLiVE Top Pharma List


The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Celebrex was produced by Pfizer.

New accounts: March

Pletal. Pain. Brand(x). Pfizer. Celebrex. Pain. Medicus London. sanofi-aventis. Eloxatin. Oncology.

In the dark

Pfizer's Celebrex and Bextra products and Merck's Vioxx received the all-clear from a 32-member FDA advisory panel in late February for continued use, despite the fact that

The notable marks

It is a telling fact that in 2005 Pfizer saw sales of its osteoporosis treatment, Celebrex, fall 47 per cent over safety concerns in the light of the Vioxx withdrawal.

Pfizer posts a rise in revenues

Many of our key products continued to perform well both in the US and international markets, including Lyrica, Celebrex, Viagra and Geodon, as well as Lipitor in the face of a

An unexpected turn

sclerosis. The trial is scheduled for completion in February 2010. Celecoxib (Celebrex; Pfizer) is a selective cyclo-oxygenase 2 inhibitor initially developed as a non-steroidal anti-inflammatory drug (NSAID) with

[ Previous 5 results ] 5 6 7 8 9 10 11 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs


Add my company
COUCH Health

We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...

Latest intelligence

The other side of … rheumatoid arthritis
For Georgie, patient activation fuelled her motivation to find life without pain. So when blood tests came back normal, she felt confident to pursue referral until RA was confirmed......
How to lessen site burden with a targeted patient recruitment strategy
Picture this: you’ve created your patient recruitment strategy and you find more and more patients are undertaking the pre-screening, you probably think – success! But then you find out, getting...
Peter Howarth
Exploring the potential of eosinophils
GSK’s Peter Howarth talks about the emerging research that suggests there is a varied role for eosinophils...